EPITHELIAL OVARIAN CARCINOMA
Clinical trials for EPITHELIAL OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new EPITHELIAL OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for EPITHELIAL OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New smart drug targets tough cancers in first human trial
Disease control Recruiting nowThis early-stage trial tests a new drug called M7437 in people with advanced solid tumors that have not responded to standard treatments. M7437 is an antibody-drug conjugate designed to deliver chemotherapy directly to cancer cells that have a specific marker (Ly6E). The study ai…
Matched conditions: EPITHELIAL OVARIAN CARCINOMA
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug cocktail aims to fight tough gynecological cancers
Disease control Recruiting nowThis study tests a drug called relacorilant, taken as a pill, combined with two standard chemotherapy drugs (nab-paclitaxel and bevacizumab) in people with ovarian, fallopian tube, peritoneal, or endometrial cancers. The goal is to see if the combination can slow cancer growth or…
Matched conditions: EPITHELIAL OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can cilastatin shield kidneys during ovarian cancer surgery?
Disease control Recruiting nowThis study compares two drugs, cilastatin and thiosulfate, for protecting the kidneys in women with ovarian cancer who undergo surgery with heated chemotherapy. About 90 patients will be randomly assigned to receive one of the drugs during the procedure. The main goal is to see w…
Matched conditions: EPITHELIAL OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: Hospital General Universitario Gregorio Marañon • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New study aims to better understand ovarian cancer recurrence
Knowledge-focused Recruiting nowThis study looks at 50 patients with ovarian cancer that has come back quickly (within 6 months). Researchers will track their health and survival to learn more about who responds best to treatment. The goal is to improve how doctors classify and care for these patients.
Matched conditions: EPITHELIAL OVARIAN CARCINOMA
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC